{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:52:09Z","timestamp":1792468329348,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jneuroim.2021.577668","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T17:23:04Z","timestamp":1626888184000},"page":"577668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Virus discovery in chronic inflammatory demyelinating polyneuropathy"],"prefix":"10.1016","volume":"358","author":[{"given":"G.G.A.","family":"van Lieverloo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.N.","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Deijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"van der Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Eftimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jneuroim.2021.577668_bb0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bjid.2018.02.005","article-title":"Prevalence of Guillain-Barre syndrome among Zika virus infected cases: a systematic review and meta-analysis","volume":"22","author":"Barbi","year":"2018","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/CMR.14.1.98-113.2001","article-title":"Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans","volume":"14","author":"Bendinelli","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","article-title":"Guillain-Barre syndrome associated with preceding hepatitis E virus infection","volume":"82","author":"van den Berg","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2021.577668_bb0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"van den Bergh","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-510X(02)00418-5","article-title":"HIV-associated Guillain-Barr\u00e9 syndrome","volume":"208","author":"Brannagan","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12879-018-3227-1","article-title":"Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults","volume":"18","author":"Dollat","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/genes10050332","article-title":"Viral metagenomics on cerebrospinal fluid","volume":"10","author":"Edridge","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jneuroim.2021.577668_bb0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/WCO.0b013e328363bfa4","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options","volume":"26","author":"Eftimov","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11904-011-0109-1","article-title":"GBV-C: state of the art and future prospects","volume":"9","author":"Giret","year":"2012","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0050","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/acn3.50946","article-title":"Antecedent infections in Guillain-Barre syndrome: a single-center, prospective study","volume":"6","author":"Hao","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0055","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2021.577668_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virusres.2018.12.010","article-title":"Enhanced bioinformatic profiling of VIDISCA libraries for virus detection and discovery","volume":"263","author":"Kinsella","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2009.11.003","article-title":"Dysregulated Epstein-Barr virus infection in patients with CIDP","volume":"218","author":"Lunemann","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/rmv.668","article-title":"Human anelloviruses and the central nervous system","volume":"20","author":"Maggi","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0075","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype","volume":"86","author":"Mathey","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2021.577668_bb0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000052111","article-title":"Diagnostic and classification criteria for the Guillain-Barre syndrome","volume":"45","author":"van der Meche","year":"2001","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0085","first-page":"327","article-title":"A case of Guillain-Barre syndrome associated with human parvovirus B19 infection","volume":"36","author":"Minohara","year":"1998","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2005.08.013","article-title":"Concomitant chronic inflammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus infection","volume":"240","author":"Mori","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016118","article-title":"A sensitive assay for virus discovery in respiratory clinical samples","volume":"6","author":"de Vries","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2021.577668_bb0100","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/v4081328","article-title":"Performance of VIDISCA-454 in feces-suspensions and serum","volume":"4","author":"de Vries","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.jneuroim.2021.577668_bb0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barre syndrome","volume":"92","author":"Wijdicks","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jneuroim.2021.577668_bb0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jnnp-2014-309964","article-title":"Sialylated IgG-fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy","volume":"87","author":"Wong","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2021.577668_bb0115","doi-asserted-by":"crossref","first-page":"631.e7","DOI":"10.1016\/j.cmi.2020.06.012","article-title":"Diagnostic accuracy of VIDISCA-NGS in patients with suspected central nervous system infections","volume":"27","author":"van Zeggeren","year":"2021","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821001958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821001958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:42:23Z","timestamp":1759048943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572821001958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":23,"alternative-id":["S0165572821001958"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577668","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus discovery in chronic inflammatory demyelinating polyneuropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"577668"}}